Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease nowadays. Currently, there is no officially approved drug to treat NAFLD. In view of the increasing global prevalence of NAFLD and an absence of treatments, the development of effective treatments is of utmost...

Descripción completa

Detalles Bibliográficos
Autores principales: Kei, Nelson, Wong, Vincent Wai Sun, Lauw, Susana, You, Lijun, Cheung, Peter Chi Keung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486587/
https://www.ncbi.nlm.nih.gov/pubmed/37685211
http://dx.doi.org/10.3390/foods12173279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486587/
https://www.ncbi.nlm.nih.gov/pubmed/37685211
http://dx.doi.org/10.3390/foods12173279

Ejemplares similares